Abstract:Obstructive Sleep Apnea (OSA) and hypertension have a high rate of co-occurrence, with OSA being a causative factor for hypertension. Sympathetic activity due to intermittent hypoxia and/or fragmented sleep is the most important mechanisms triggering the elevation in blood pressure in OSA. OSA-related hypertension is characterized by resistant hypertension, nocturnal hypertension, abnormal blood pressure variability, and vascular remodeling. In particular, the prevalence of OSA is high in patients with resistant hypertension, and the mechanism proposed includes vascular remodeling due to the exacerbation of arterial stiffness by OSA. Continuous positive airway pressure therapy is effective at lowering blood pressure, however, the magnitude of the decrease in blood pressure is relatively modest, therefore, patients often need to also take antihypertensive medications to achieve optimal blood pressure control. Antihypertensive medications targeting sympathetic pathways or the renin-angiotensin-aldosterone system have theoretical potential in OSA-related hypertension, Therefore, beta-blockers and renin-angiotensin system inhibitors may be effective in the management of OSA-related hypertension, but current evidence is limited. The characteristics of OSA-related hypertension, such as nocturnal hypertension and obesity-related hypertension, suggests potential for angiotensin receptor-neprilysin inhibitor (ARNI), sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucose-dependent insulinotropic polypeptide receptor/ glucagon-like peptide-1 receptor agonist (GIP/GLP-1 RA). Recently, OSA has been considered to be caused not only by upper airway anatomy but also by several non-anatomic mechanisms, such as responsiveness of the upper airway response, ventilatory control instability, and reduced sleep arousal threshold. Elucidating the phenotypic mechanisms of OSA may potentially advance more personalized hypertension treatment strategies in the future.

Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome as a cause of resistant hypertension

Obstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy

Association of Obstructive Sleep Apnea with Hypertension: A Systematic Review and Meta-Analysis.

Obstructive Sleep Apnea Syndrome is a Risk Factor of Hypertension.

Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship

The Role of Aldosterone in OSA and OSA-Related Hypertension

Association between imbalanced gut microecology and obstructive sleep apnea-associated hypertension: A prospective observational study

Arousal and hypoxia in patients with obstructive sleep apnea-hypopnean syndrome combined with hypertension

Sleeping unsoundly: CPAP and its complexities in treating sleep apnoea hypertension

Explore the relationship of obstructive sleep apnea syndrome and hypertension

Analysis of Polysomnography Results in Patients with Obstructive Sleep Apnea Syndrome Accompanied Hypertension

Analysis of the Relationship of Obstructive Sleep Apnea Syndrome with Hypertension

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome

Research progress on the relationship between obstructive sleep apnea syndrome and diseases of the respiratory and circulatory systems

Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management

[The Role of Adhesion Molecules in the Pathogenic Mechanisms of Hypertension in Obstructive Sleep Apnea-Hypopnea Syndrome].

Characteristics of Hypertension in Obstructive Sleep Apnea: an Asian Experience

Hypertension in Children with Obstructive Sleep Apnea Syndrome—Age, Weight Status, and Disease Severity

The relationship of obstructive sleep apnea-hypopnea syndrome with hypertension and insulin resistance